Neuphoria Therapeutics Inc (NEUP) — Free Cash Flow Generation Index

Latest as of June 2025: 1.00x

Neuphoria Therapeutics Inc (NEUP) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of $73.57 Million represents 1% of operating cash flow ($73.57 Million). See Neuphoria Therapeutics Inc (NEUP) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$73.57 Million
USD

Operating Cash Flow

$73.57 Million
USD

Capital Expenditures

$3.00
USD

Neuphoria Therapeutics Inc Free Cash Flow Generation Index (2015–2025)

Historical FCF Generation Index trend for Neuphoria Therapeutics Inc across 2 annual periods. Explore NEUP operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Neuphoria Therapeutics Inc (2015–2025)

Year-by-year Free Cash Flow Generation Index for Neuphoria Therapeutics Inc. For the full company profile including market capitalisation, see market value of Neuphoria Therapeutics Inc.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 1.00x $77.23 Million $77.23 Million $0.00 ▲ +57.4%
2015 0.64x $3.14 Million $4.94 Million $649.08K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).